Rafferty Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Rafferty Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,941	Closed	-$428K	–	1183
2020 Q4	$428K	Buy	+5,941	New	+$311K	﹤0.01%	717
2019 Q2	–	Sell	-7,791	Closed	-$488K	–	879
2019 Q1	$488K	Sell	7,791 -721	-8%	-$49.5K	0.01%	680
2018 Q4	$508K	Sell	8,512 -4,921	-37%	-$295K	0.01%	512
2018 Q3	$866K	Buy	+13,433	New	+$750K	0.01%	472

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Rafferty Asset Management's BEAT Position: Q1 2021 in Review

Rafferty Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,941 shares — an estimated $428K sold.

Rafferty Asset Management first reported a position in BEAT in Q3 2018 and held it in 4 quarters. The position peaked at $866K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Rafferty Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Rafferty Asset Management sold 5,941 BioTelemetry, Inc. shares in Q1 2021, an estimated $428K.
Rafferty Asset Management first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 4 quarters.
Rafferty Asset Management's BioTelemetry, Inc. position peaked at $866K in Q3 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Rafferty Asset Management's 13F filing for Q1 2021, filed 10 May 2021.